AORT Stock Analysis: Buy, Sell, or Hold?
AORT - Artivion, Inc.
$20.58
0.16 (0.78%)
▲
5d:
-9.58%
30d:
-42.08%
90d:
-46.55%
HOLD
LOW Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: May 07, 2026
0d
Get Alerted When AORT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: AORT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: AORT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$37.65
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$23.38
12.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AORT is currently trading at $20.58, which is considered oversold relative to its 30-day fair value range of $20.74 to $33.26. From a valuation perspective, the stock is trading at a discount (Forward PE: 26.6) compared to its historical average (39.3). Remarkably, the market is currently pricing in an annual earnings decline of 12.2% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, AORT is in a strong downtrend. The price is currently testing key support at $20.00. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: AORT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (21th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $42.00 (+104.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, AORT is in a strong downtrend. The price is currently testing key support at $20.00. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: AORT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (21th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $42.00 (+104.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$20.74 -
$33.26
Company Quality Score
59/100
(HOLD)
Options IV Signal
21th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
92.3%
Protect Your Profits
Holding AORT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 21th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 104.1% below Wall St target ($42.00)
- CAUTION: Recommendation downgraded due to -9.6% 5-day decline
Trading Range Analysis
30-Day Trading Range
$20.74 -
$33.26
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$1.09
(5.3%)
Support & Resistance Levels
Support Level
$20.00
Resistance Level
$23.60
Current Trend
Strong Downtrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
26.61
Wall Street Target
$42.00
(+104.1%)
Revenue Growth (YoY)
17.5%
Profit Margin
2.5%
Valuation Discount vs History
-12.2% cheaper
PE vs Historical
26.6 vs 39.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-12.2%
(market-implied from PE analysis)
1-Year Target
$18.52
(-10%)
2-Year Target
$16.67
(-19%)
3-Year Target
$15.00
(-27%)
3-Yr Target (if PE normalizes)
(PE: 27→39)
$22.15
(+8%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 26.6, Growth: 56.8%)
$69.46
(+238%)
Base:
(SPY PE: 21.9, Growth: 56.8%)
$57.18
(+178%)
Bear:
(PE: 18.6, Growth: 56.8%)
$48.61
(+136%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (90x PE), but valuation improves significantly next year (27x PE) as earnings recover.
Trailing PE: 89.84 | Current EPS (TTM): $0.25
Bull Case
$49.41
(+119%)
Analyst growth 100.0%, PE expands to 98.8
Base Case
$44.92
(+99%)
Market implied 100.0%, PE stable at 89.8
Bear Case
$15.27
(-32%)
Severe decline -20.0%, PE contracts to 76.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 26.6 to 39.3
Stabilization Target:
$30.39
(+47.7%)
PE Expansion Potential:
+47.7%
Share & Embed Analysis
Last updated: June 04, 2026 2:41 AM ET
Data refreshes hourly during market hours. Next update: 3:41 AM
Data refreshes hourly during market hours. Next update: 3:41 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AORT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Jean F Holloway
SELL
8962 shares
2026-03-04
Marshall S Stanton
SELL
2149 shares
2026-03-03
Lance A Berry
SELL
6316 shares
2026-03-03
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$83 | 54 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$82 | 64 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$389 | 49 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$247 | 62 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$107 | 61 BUY |
Advanced AORT Option Strategies
Professional options setups generated by AI based on today's AORT price and gamma walls.
